Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Anika Therapeutics Inc's Business Segments
Anika Therapeutics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
1
Largest Segment
Single Reportable Segment
Total Revenue
$ 33
Regions Reported
1
Revenue Share by Reportable Segment - Q2 FY2026
- Single Reportable Segment100%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single Reportable Segment | $ 33 | 100% |
Revenue Share by Region - Q2 FY2026
- Europe21%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 7 | 21% |
Revenue by Product & Service Category - Q2 FY2026
- OEM Channel57.4%
- Commercial Channel42.6%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| OEM Channel | $ 19 | 57.4% |
| Commercial Channel | $ 14 | 42.6% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Anika Therapeutics Inc
Anika Therapeutics Inc is a global medical technology company that specializes in tissue-medical devices for the regenerative treatment of pain and musculoskeletal conditions. The company is headquartered in Bedford, Massachusetts, USA, and operates in over 30 countries worldwide.
Anika Therapeutics Inc was founded in 1992 by Charles H. Sherwood, Ph.D., and Richard G. Steadman, M.D, with a vision to create and deliver products that could help to promote the healing and recovery of individuals suffering from musculoskeletal injuries or diseases. The company has since grown to become a leading provider of advanced medical devices and therapies, using a range of technologies developed in-house.
The company's core product offering includes a number of tissue implants, including Orthovisc, Monovisc, and Cingal, which are designed to help alleviate the pain and mobility issues experienced by patients with osteoarthritis. These devices, which are made using high-purity hyaluronic acid, are injected into the joint to lubricate and cushion the affected area, providing long-lasting relief.
In addition to these products, Anika Therapeutics Inc also offers a range of other medical devices and solutions, such as the AmnioExcel amniotic membrane product, which is used in wound healing, and the Hyalofast scaffold, which allows for the delivery of cells and growth factors in tissue engineering repair applications.
Anika Therapeutics Inc is proud of its commitment to quality and innovation, investing heavily in research and product development to improve the efficacy and range of its medical solutions. The company has a strong record of innovation, having filed over 100 patents to date, and regularly collaborates with leading medical institutions and industry partners to develop and improve its products.
Overall, Anika Therapeutics Inc offers a diverse range of innovative, high-quality medical solutions designed to address a range of musculoskeletal concerns, improving patient outcomes and quality of life. Its focus on quality, innovation, and collaboration has helped establish it as a leader in the industry, and it continues to grow and expand its product offerings to address the evolving needs of patients worldwide.
Anika Therapeutics Inc was founded in 1992 by Charles H. Sherwood, Ph.D., and Richard G. Steadman, M.D, with a vision to create and deliver products that could help to promote the healing and recovery of individuals suffering from musculoskeletal injuries or diseases. The company has since grown to become a leading provider of advanced medical devices and therapies, using a range of technologies developed in-house.
The company's core product offering includes a number of tissue implants, including Orthovisc, Monovisc, and Cingal, which are designed to help alleviate the pain and mobility issues experienced by patients with osteoarthritis. These devices, which are made using high-purity hyaluronic acid, are injected into the joint to lubricate and cushion the affected area, providing long-lasting relief.
In addition to these products, Anika Therapeutics Inc also offers a range of other medical devices and solutions, such as the AmnioExcel amniotic membrane product, which is used in wound healing, and the Hyalofast scaffold, which allows for the delivery of cells and growth factors in tissue engineering repair applications.
Anika Therapeutics Inc is proud of its commitment to quality and innovation, investing heavily in research and product development to improve the efficacy and range of its medical solutions. The company has a strong record of innovation, having filed over 100 patents to date, and regularly collaborates with leading medical institutions and industry partners to develop and improve its products.
Overall, Anika Therapeutics Inc offers a diverse range of innovative, high-quality medical solutions designed to address a range of musculoskeletal concerns, improving patient outcomes and quality of life. Its focus on quality, innovation, and collaboration has helped establish it as a leader in the industry, and it continues to grow and expand its product offerings to address the evolving needs of patients worldwide.
Anika Therapeutics Inc. is a prominent medical technology company focused on developing and manufacturing advanced therapeutic products aimed at tissue repair and regeneration across various medical fields. The company’s comprehensive product portfolio is categorized into multiple segments, with a robust selection of innovative products and services tailored for orthopedic, surgical, and ophthalmic applications.
Segments
1. Orthobiologics:
This segment encompasses a diverse range of products that address orthopedic conditions, particularly those related to joint pain and tissue repair. The products in this category are pivotal in managing musculoskeletal issues such as osteoarthritis, tendonitis, ligament injuries, and cartilage degradation. These therapies are designed to enhance joint function and alleviate discomfort, thereby aiding in the recovery of patients with various orthopedic ailments.
2. Surgical:
The surgical segment focuses on products that facilitate surgical procedures by improving surgical outcomes and promoting tissue regeneration during and after surgery. These products are utilized in a variety of surgical applications, aiming to enhance recovery times and support the healing process, making them invaluable in orthopedic surgeries and others requiring tissue repair.
3. Ophthalmic:
This segment includes therapeutic products tailored for eye care. These products address conditions such as dry eye syndrome, corneal injuries, and other ophthalmic disorders. By providing lubrication and protection to ocular tissues, these solutions help in managing symptoms and supporting ocular health.
Products
1. Orthovisc:
A hyaluronic acid-based injectable treatment specifically designed for patients suffering from knee osteoarthritis. Orthovisc acts as a lubricant and cushion within the joint, alleviating pain and improving mobility while facilitating the body’s natural healing processes.
2. Cingal:
This innovative combination product integrates hyaluronic acid with a corticosteroid, providing dual benefits in the treatment of knee osteoarthritis. Cingal delivers both immediate pain relief and longer-lasting therapeutic effects, addressing inflammation and enhancing joint function.
3. Hyalosyn:
Another hyaluronic acid-based solution, Hyalosyn is formulated for hip osteoarthritis treatment. By improving joint lubrication and reducing discomfort, this product aids patients in regaining mobility and improving their overall quality of life.
4. Orthofix:
A specialized bone growth factor utilized in various orthopedic applications, Orthofix facilitates bone regeneration and is commonly used in spinal fusion surgeries. This product plays a crucial role in enhancing skeletal healing and restoration following surgical interventions.
5. ELEVESS:
A versatile dermal filler used in cosmetic dermatology, ELEVESS is designed to restore volume to the skin and smooth out facial wrinkles. Its aesthetic applications position it as a key contributor to non-surgical cosmetic procedures aimed at enhancing appearance and rejuvenating the skin.
Services
1. Orthopedic Consultations:
Anika Therapeutics offers orthopedic consultations to assist patients in exploring treatment options for a myriad of orthopedic conditions. These consultations facilitate informed decision-making regarding potential therapies available to them.
2. Education and Support Services:
The company provides extensive educational materials and support services to healthcare providers and patients alike. These resources are invaluable in promoting understanding of Anika’s products, as well as best practices for treatment and care.
3. Clinical Trials:
Anika Therapeutics actively conducts clinical trials to assess the safety and efficacy of its product offerings. This research is crucial not only for regulatory compliance but also for the continuous development of innovative therapies that meet the evolving needs of patients and healthcare providers.
4. Sales and Distribution:
Anika Therapeutics markets its products directly to physicians and healthcare providers as well as through a network of distributors around the globe. This extensive sales and distribution strategy ensures broad access to its therapeutic solutions, enhancing the availability of its products across various healthcare settings.
In summary, Anika Therapeutics Inc. is dedicated to delivering state-of-the-art products and services that significantly improve patient outcomes in the domains of orthopedic care, surgical recovery, and dermatological aesthetics. By focusing on innovative solutions for tissue repair and regeneration, the company continues to set the standard in medical technology, responding to the needs of healthcare providers and patients with its diverse therapeutic offerings.
Segments
1. Orthobiologics:
This segment encompasses a diverse range of products that address orthopedic conditions, particularly those related to joint pain and tissue repair. The products in this category are pivotal in managing musculoskeletal issues such as osteoarthritis, tendonitis, ligament injuries, and cartilage degradation. These therapies are designed to enhance joint function and alleviate discomfort, thereby aiding in the recovery of patients with various orthopedic ailments.
2. Surgical:
The surgical segment focuses on products that facilitate surgical procedures by improving surgical outcomes and promoting tissue regeneration during and after surgery. These products are utilized in a variety of surgical applications, aiming to enhance recovery times and support the healing process, making them invaluable in orthopedic surgeries and others requiring tissue repair.
3. Ophthalmic:
This segment includes therapeutic products tailored for eye care. These products address conditions such as dry eye syndrome, corneal injuries, and other ophthalmic disorders. By providing lubrication and protection to ocular tissues, these solutions help in managing symptoms and supporting ocular health.
Products
1. Orthovisc:
A hyaluronic acid-based injectable treatment specifically designed for patients suffering from knee osteoarthritis. Orthovisc acts as a lubricant and cushion within the joint, alleviating pain and improving mobility while facilitating the body’s natural healing processes.
2. Cingal:
This innovative combination product integrates hyaluronic acid with a corticosteroid, providing dual benefits in the treatment of knee osteoarthritis. Cingal delivers both immediate pain relief and longer-lasting therapeutic effects, addressing inflammation and enhancing joint function.
3. Hyalosyn:
Another hyaluronic acid-based solution, Hyalosyn is formulated for hip osteoarthritis treatment. By improving joint lubrication and reducing discomfort, this product aids patients in regaining mobility and improving their overall quality of life.
4. Orthofix:
A specialized bone growth factor utilized in various orthopedic applications, Orthofix facilitates bone regeneration and is commonly used in spinal fusion surgeries. This product plays a crucial role in enhancing skeletal healing and restoration following surgical interventions.
5. ELEVESS:
A versatile dermal filler used in cosmetic dermatology, ELEVESS is designed to restore volume to the skin and smooth out facial wrinkles. Its aesthetic applications position it as a key contributor to non-surgical cosmetic procedures aimed at enhancing appearance and rejuvenating the skin.
Services
1. Orthopedic Consultations:
Anika Therapeutics offers orthopedic consultations to assist patients in exploring treatment options for a myriad of orthopedic conditions. These consultations facilitate informed decision-making regarding potential therapies available to them.
2. Education and Support Services:
The company provides extensive educational materials and support services to healthcare providers and patients alike. These resources are invaluable in promoting understanding of Anika’s products, as well as best practices for treatment and care.
3. Clinical Trials:
Anika Therapeutics actively conducts clinical trials to assess the safety and efficacy of its product offerings. This research is crucial not only for regulatory compliance but also for the continuous development of innovative therapies that meet the evolving needs of patients and healthcare providers.
4. Sales and Distribution:
Anika Therapeutics markets its products directly to physicians and healthcare providers as well as through a network of distributors around the globe. This extensive sales and distribution strategy ensures broad access to its therapeutic solutions, enhancing the availability of its products across various healthcare settings.
In summary, Anika Therapeutics Inc. is dedicated to delivering state-of-the-art products and services that significantly improve patient outcomes in the domains of orthopedic care, surgical recovery, and dermatological aesthetics. By focusing on innovative solutions for tissue repair and regeneration, the company continues to set the standard in medical technology, responding to the needs of healthcare providers and patients with its diverse therapeutic offerings.